IPP Bureau

Dr. Jitendra Singh inaugurates 10th Annual
Dr. Jitendra Singh inaugurates 10th Annual "Cell and Gene Therapy" symposium

By IPP Bureau - October 11, 2025

Several technologies for hemoglobinopathies are being transferred to commercial partners

Botanic Healthcare unveils PeptiGlow and LipoLush for beauty and wellness
Botanic Healthcare unveils PeptiGlow and LipoLush for beauty and wellness

By IPP Bureau - October 11, 2025

PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration

Allergan Aesthetics launches SkinMedica’s reimagined packaging
Allergan Aesthetics launches SkinMedica’s reimagined packaging

By IPP Bureau - October 11, 2025

SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer

Delhi High Court refuses to restrain Natco from manufacturing spinal muscular atrophy drug
Delhi High Court refuses to restrain Natco from manufacturing spinal muscular atrophy drug

By IPP Bureau - October 10, 2025

The Court dismissed Swiss drugmaker Roche’s plea for interim injunction

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease

By IPP Bureau - October 10, 2025

Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants

Bayer and Kumquat initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors
Bayer and Kumquat initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors

By IPP Bureau - October 10, 2025

First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors

AstraZeneca to increase investment in Virginia manufacturing facility to $4.5 billion
AstraZeneca to increase investment in Virginia manufacturing facility to $4.5 billion

By IPP Bureau - October 10, 2025

Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America

Thermo Fisher launches new test to assess lung transplant rejection
Thermo Fisher launches new test to assess lung transplant rejection

By IPP Bureau - October 10, 2025

New gene expression profiling test enhances precision in assessing lung transplant rejection and injury

Jubilant HollisterStier launches new sterile fill & finish line at its Spokane facility in US
Jubilant HollisterStier launches new sterile fill & finish line at its Spokane facility in US

By IPP Bureau - October 10, 2025

The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision

Integris Medtech files DRHP with SEBI for IPO
Integris Medtech files DRHP with SEBI for IPO

By IPP Bureau - October 10, 2025

The company plans to use the funds raised from the net proceeds to repay or prepay certain loans

Coveris and SABIC pioneer closed-loop recycling for medical packaging
Coveris and SABIC pioneer closed-loop recycling for medical packaging

By IPP Bureau - October 10, 2025

The initiative successfully demonstrates that used medical plastic packaging can be recycled and transformed back into new, contact-sensitive medical packaging

Lonza receives Swissmedic approval for Biologics drug product filling line in Stein
Lonza receives Swissmedic approval for Biologics drug product filling line in Stein

By IPP Bureau - October 09, 2025

New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain

Lilly’s Omvoh shows sustained 4-year efficacy in ulcerative colitis
Lilly’s Omvoh shows sustained 4-year efficacy in ulcerative colitis

By IPP Bureau - October 09, 2025

Lilly's Omvoh is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka
WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka

By IPP Bureau - October 09, 2025

WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030

Lupin launches partnership program to expand global reach of PrecisionSphere injectable platform
Lupin launches partnership program to expand global reach of PrecisionSphere injectable platform

By IPP Bureau - October 09, 2025

Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles

Latest Stories

Interviews

Packaging